Lipidic carriers of siRNA: differences in the formulation, cellular uptake, and delivery with plasmid DNA.

RNA interference (RNAi) has become a popular tool for downregulating specific gene expression in many species, including mammalian cells [Novina, C. D., and Sharp, P. A. (2004) The RNAi revolution, Nature 430, 161-164]. Synthetic double-stranded RNA sequences (siRNA) of 21-23 nucleotides have been shown in particular to have the potential to silence specifically gene function in cultured mammalian cells. As a result, there has been a significant surge of interest in the application of siRNA in functional genomics programs as a means of deciphering specific gene function. However, for siRNA functional genomics studies to be valuable and effective, specific silencing of any given target gene is essential, devoid of nonspecific knockdown and toxic side effects. For this reason, we became interested in investigating cationic liposome/lipid-mediated siRNA delivery (siFection) as a meaningful and potentially potent way to facilitate effective functional genomics studies. Accordingly, a number of cationic liposome/lipid-based systems were selected, and their formulation with siRNA was studied, with particular emphasis on formulation parameters most beneficial for siRNA use in functional genomics studies. Cationic liposome/lipid-based systems were selected from a number of commercially available products, including lipofectAMINE2000 and a range of CDAN/DOPE systems formulated from different molar ratios of the cationic cholesterol-based polyamine lipid N(1)-cholesteryloxycarbonyl-3,7-diazanonane-1,9-diamine (CDAN) and the neutral helper lipid dioleoyl-L-alpha-phosphatidylethanolamine (DOPE). Parameters that were been investigated included the lipid:nucleic acid ratio of mixing, the extent of cationic liposome/lipid-nucleic acid complex (lipoplex) formation plus medium used, the lipoplex particle size, the mode of delivery, and dose-response effects. Results suggest that concentrations during siRNA lipoplex (LsiR) formation are crucial for maximum knockdown, but the efficacy of gene silencing is not influenced by the size of LsiR particles. Most significantly, results show that most commercially available cationic liposome/lipid-based systems investigated here mediate a significant nonspecific downregulation of the total cellular protein content at optimal doses for maximal specific gene silencing and knockdown. Furthermore, one pivotal aspect of using siRNA for functional genomics studies is the need for at least minimal cellular toxicity. Results demonstrate that CDAN and DOPE with and without siRNA confer low toxicity to mammalian cells, whereas lipofectAMINE2000 is clearly toxic both as a reagent and after formulation into LsiR particles. Interestingly, LsiR particles formulated from CDAN and DOPE (45:55, m/m; siFECTamine) seem to exhibit a slower cellular uptake than LsiR particles formulated from lipofectAMINE2000. Intracellularly, LsiR particles formulated from CDAN and DOPE systems also appear to behave differently, amassing in distinct but diffuse small nonlysosomal compartments for at least 5 h after siFection. By contrast, LsiR particles formulated from lipofectAMINE2000 accumulate in fewer larger intracellular vesicles.

[1]  D. Scherman,et al.  Plasmid DNA size does not affect the physicochemical properties of lipoplexes but modulates gene transfer efficiency. , 1999, Nucleic acids research.

[2]  M. Okabe,et al.  Small interfering RNA and gene silencing in transgenic mice and rats , 2002, FEBS letters.

[3]  A. Caudy,et al.  Argonaute2, a Link Between Genetic and Biochemical Analyses of RNAi , 2001, Science.

[4]  N. M. Rao,et al.  Cationic lipids for gene delivery in vitro and in vivo , 2006 .

[5]  D. Papahadjopoulos,et al.  Liposomes revisited , 1995, Science.

[6]  Andrew D. Miller,et al.  Biophysical characterization of the DNA binding and condensing properties of adenoviral core peptide mu. , 2002, Biochemistry.

[7]  S. Fesik,et al.  Specificity of short interfering RNA determined through gene expression signatures , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[8]  J. Capeau,et al.  Liposomes enhance delivery and expression of an RGD-oligolysine gene transfer vector in human tracheal cells , 1998, Gene Therapy.

[9]  A. Fire,et al.  Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans , 1998, Nature.

[10]  G. Abbott,et al.  RNA Interference Reveals That EndogenousXenopus MinK-related Peptides Govern Mammalian K+ Channel Function in Oocyte Expression Studies* , 2003, The Journal of Biological Chemistry.

[11]  Y. Barenholz,et al.  Phase Behavior, DNA Ordering, and Size Instability of Cationic Lipoplexes , 2001, The Journal of Biological Chemistry.

[12]  K. Becker,et al.  Antisense DNAs as multisite genomic modulators identified by DNA microarray , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[13]  L. Pietrasanta,et al.  DNA toroids: stages in condensation. , 1999, Biochemistry.

[14]  Y. Barenholz,et al.  Lamellarity of cationic liposomes and mode of preparation of lipoplexes affect transfection efficiency. , 1999, Biochimica et biophysica acta.

[15]  Eric Perouzel,et al.  Nuclear Localisation Sequence Templated Nonviral Gene Delivery Vectors: Investigation of Intracellular Trafficking Events of LMD and LD Vector Systems , 2003, Chembiochem : a European journal of chemical biology.

[16]  Y. Barenholz,et al.  Characterization of DNA-lipid complexes commonly used for gene delivery. , 1999, International journal of pharmaceutics.

[17]  K. Ui-Tei,et al.  Guidelines for the selection of highly effective siRNA sequences for mammalian and chick RNA interference. , 2004, Nucleic acids research.

[18]  H. Inokuchi,et al.  Gene transfer vectors based on Sendai virus. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[19]  R. Juliano,et al.  Evaluating the Specificity of Antisense Oligonucleotide Conjugates , 2002, The Journal of Biological Chemistry.

[20]  Andrew D. Miller,et al.  Thermodynamic aspects and biological profile of CDAN/DOPE and DC-Chol/DOPE lipoplexes. , 2003, Biochemistry.

[21]  M. Carmell,et al.  Posttranscriptional Gene Silencing in Plants , 2006 .

[22]  Howard Y. Chang,et al.  Genomewide view of gene silencing by small interfering RNAs , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[23]  P. Ross,et al.  Lipoplex size is a major determinant of in vitro lipofection efficiency , 1999, Gene Therapy.

[24]  Robert H. Silverman,et al.  Activation of the interferon system by short-interfering RNAs , 2003, Nature Cell Biology.

[25]  D. Hoekstra,et al.  Interference of poly(ethylene glycol)-lipid analogues with cationic-lipid-mediated delivery of oligonucleotides; role of lipid exchangeability and non-lamellar transitions. , 2002, The Biochemical journal.

[26]  R. Iggo,et al.  Induction of an interferon response by RNAi vectors in mammalian cells , 2003, Nature Genetics.

[27]  O. Zelphati,et al.  Stable and monodisperse lipoplex formulations for gene delivery , 1998, Gene Therapy.

[28]  Andrew D. Miller,et al.  Physico-chemical analysis of cationic liposome–DNA complexes (lipoplexes) with respect to in vitro and in vivo gene delivery efficiency , 2001 .

[29]  B. Reinhart,et al.  A biochemical framework for RNA silencing in plants. , 2003, Genes & development.

[30]  A. Pasquinelli,et al.  A Cellular Function for the RNA-Interference Enzyme Dicer in the Maturation of the let-7 Small Temporal RNA , 2001, Science.

[31]  G. Macino,et al.  Involvement of small RNAs and role of the qde genes in the gene silencing pathway in Neurospora. , 2002, Genes & development.

[32]  V. Bloomfield,et al.  DNA condensation. , 1996, Current opinion in structural biology.

[33]  I. Brukner,et al.  Cellular proteins prevent antisense phosphorothioate oligonucleotide (SdT18) to target sense RNA (rA18): development of a new in vitro assay. , 2000, Biochemistry.

[34]  V. Bloomfield,et al.  Condensation of DNA by multivalent cations: Considerations on mechanism , 1991, Biopolymers.

[35]  J. Northrop,et al.  Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[36]  T. Tuschl,et al.  Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells , 2001, Nature.

[37]  Phillip A. Sharp,et al.  The RNAi revolution , 2004, Nature.

[38]  H. Hansma,et al.  DNA condensation for gene therapy as monitored by atomic force microscopy. , 1998, Nucleic acids research.

[39]  A. Caudy,et al.  Role for a bidentate ribonuclease in the initiation step of RNA interference , 2001 .

[40]  Mouldy Sioud,et al.  Gene silencing by systemic delivery of synthetic siRNAs in adult mice. , 2003, Journal of molecular biology.

[41]  C. Stein,et al.  Does antisense exist? , 1995, Nature Medicine.

[42]  H. L. Sänger,et al.  RNA-directed de novo methylation of genomic sequences in plants , 1994, Cell.